MedKoo Cat#: 555461 | Name: BKI-1770

Description:

WARNING: This product is for research use only, not for human or veterinary use.

BKI-1770 is a Bumped-Kinase Inhibitor for Cryptosporidiosis Therapy.

Chemical Structure

BKI-1770
BKI-1770
CAS#Unknown

Theoretical Analysis

MedKoo Cat#: 555461

Name: BKI-1770

CAS#: Unknown

Chemical Formula: C21H26N4O3

Exact Mass: 382.2005

Molecular Weight: 382.46

Elemental Analysis: C, 65.95; H, 6.85; N, 14.65; O, 12.55

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
BKI-1770; BKI 1770; BKI1770;
IUPAC/Chemical Name
5-Amino-3-(6-ethoxynaphthalen-2-yl)-1-(4-hydroxy-2-methylbutan-2-yl)-1H-pyrazole-4-carboxamide
InChi Key
OBPBNYWSAYFJIX-UHFFFAOYSA-N
InChi Code
InChI=1S/C21H26N4O3/c1-4-28-16-8-7-13-11-15(6-5-14(13)12-16)18-17(20(23)27)19(22)25(24-18)21(2,3)9-10-26/h5-8,11-12,26H,4,9-10,22H2,1-3H3,(H2,23,27)
SMILES Code
O=C(C1=C(N)N(C(CCO)(C)C)N=C1C2=CC=C3C=C(OCC)C=CC3=C2)N
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Cryptosporidium is a leading cause of pediatric diarrhea worldwide. Currently, there is neither a vaccine nor a consistently effective drug available for this disease.

Preparing Stock Solutions

The following data is based on the product molecular weight 382.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy Wenlin Huang, Matthew A. Hulverson, Ryan Choi, Samuel L. M. Arnold, Zhongsheng Zhang, Molly C. McCloskey, Grant R. Whitman, Robert C. Hackman, Kasey L. Rivas, Lynn K. Barrett, Kayode K. Ojo, Wesley C. Van Voorhis, and Erkang Fan Publication Date (Web): March 4, 2019 (Article) DOI: 10.1021/acs.jmedchem.9b00069